Background & Aims
Abbreviations used in this paper:BMI (body mass index), CAP (controlled attenuation parameter), LSM (liver stiffness measurement), NHANES (National Health and Nutrition Examination Survey), USDA (US Department of Agriculture)
- Contemporary epidemiology of chronic liver disease and cirrhosis.Clin Gastroenterol Hepatol. 2020; 18: 2650-2666
- Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis.Clin Gastroenterol Hepatol. 2013; 11: 1413-1421. e1
- Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.Hepatology. 2009; 50: 1360-1369
- Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis.Aliment Pharmacol Ther. 2016; 43: 562-574
- Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis.Hepatology. 2012; 55: 429-436
- Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort.Gastroenterology. 2015; 148: 118-125
- Healthy user and related biases in observational studies of preventive interventions: a primer for physicians.J Gen Intern Med. 2011; 26: 546-550
- Sugar-sweetened beverages are associated with increased liver stiffness and steatosis among apparently healthy adults in the United States.Clin Gastroenterol Hepatol. 2021; (Epub ahead of print)
- American Gastroenterological Association Institute technical review on the role of elastography in chronic liver diseases.Gastroenterology. 2017; 152: 1544-1577
- Update of the healthy eating index: HEI-2015.J Acad Nutr Diet. 2018; 118: 1591-1602
- Protective effects of coffee consumption following liver transplantation for hepatocellular carcinoma in cirrhosis.Aliment Pharmacol Ther. 2019; 49: 779-788
- All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank study.BMC Public Health. 2021; 21: 970
- Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins.Hepatology. 2010; 52: 1652-1661
- Adenosine A2A receptors play a role in the pathogenesis of hepatic cirrhosis.Br J Pharmacol. 2006; 148: 1144-1155
Feng L, Tapper EB, Sun X, et al. Purinergic modulation and CD39/ENTPD1 in cancer. Frontiers in anti-cancer drug discovery. Beijing, China: Bentham Science Publishers, 2014:229–292.
- Effects of coffee consumption in chronic hepatitis C: a randomized controlled trial.Dig Liver Dis. 2013; 45: 499-504
- Inverse associations of total and decaffeinated coffee with liver enzyme levels in National Health and Nutrition Examination Survey 1999-2010.Hepatology. 2014; 60: 2091-2098
Publication stageIn Press Journal Pre-Proof
Conflicts of interest This author discloses the following: Elliot Tapper has served as a consultant to Norvartis, Axcella, and Allergan; has served on advisory boards for Mallinckrodt, Bausch Health, Kaleido, and Novo Nordisk; and has received unrestricted research grants from Gilead and Valeant. The remaining authors disclose no conflicts.
Funding Supported by the National Institutes of Health through the National Institute of Diabetes and Digestive and Kidney Diseases grant 1K23DK117055 (E.T.).